Ask AI
ProCE Banner Activity

My Journey With HS: What Every HCP Needs to Know About the Patient Experience

Clinical Thought

Many patients with hidradenitis suppurativa (HS) go years before they receive a confirmed HS diagnosis and appropriate treatment. Through a detailed patient perspective, learn about the persistent challenges of recognizing HS that patients and healthcare professionals face, the clinical and personal impact of a delayed diagnosis, and how emerging biologic therapies are changing the game.

Released: July 29, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with HS Foundation and Integrative Dermatology Symposium/LearnSkin.

ProCE Banner

Supporters

Supported by an educational grant from Incyte Corporation.

Incyte Corporation

Partners

HS Foundation

ProCE Banner

Integrative Dermatology Symposium/LearnSkin

ProCE Banner

Target Audience

This activity is intended for dermatologists, nurse practitioners, physician associates, and other HCPs who care for people living with hidradenitis suppurativa.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Implement structured diagnostic and staging frameworks to reduce time-to-diagnosis and mitigate irreversible tissue damage in patients with HS

  • Individualize advanced therapeutic strategies by integrating efficacy benchmarks, safety considerations, and patient-reported outcomes into shared decision-making discussions

Additional Disclosures

Generative artificial intelligence (AI) tools were used for revising or refining educational content. All AI-assisted content underwent human review, editing, and validation by qualified faculty and accredited education staff to ensure scientific accuracy, balance, and compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education.